Sign In

David B. Feder, Esq

Cannabis Business, Licensing and Litigation Attorney | Cannabis License Applications | Investment Due Diligence | General Counsel | Start-up Advisor | Cannabis Real Estate Broker

David B. Feder, Esq, is a prominent cannabis business lawyer and a founding member of Weed Law, a full-service cannabis business firm in Manhattan.

With over a decade of experience in the cannabis industry, David Feder has been instrumental in shaping the legal landscape of this rapidly evolving field and has successfully obtained the first adult-use cannabis licenses in both New York and New Jersey.

Specializing in licensing, contracts, litigation, and deal negotiation, David has a proven track record of resolving complex issues, high-stakes disputes, and providing innovative legal solutions to empower clients and seize strategic opportunities.

David Feder holds a Juris Doctor (JD) from Brooklyn Law School, a Bachelor of Business Administration in Corporate Finance from Queens College, City University of New York, and has pursued additional education in the medical and recreational cannabis industry.

In addition to his legal expertise, David Feder has held various roles such as a Licensed Real Estate Broker, VP of Behavioral Research Division, Co-Founder of NY Medical Cannabis Business, and Continuing Legal Education (CLE) Lecturer on cannabis business.

Throughout his career, David Feder has been actively involved in organizations such as the New York City Bar Association and has spoken at legal events on the regulatory future of marijuana laws and cannabis opportunities.

David's passion lies in providing tailored legal and consulting services to meet the specific needs and objectives of each client, whether working independently or collaboratively with industry experts and executives.

His diverse background, encompassing legal, business, and cannabis industry knowledge, positions him as a versatile and sought-after professional in the cannabis business sector.

Highlights

Jul 9 · linkedin

Hot off the press. Brand new licenses coming out from OCM. Sure they’re going completely out of order and icing our licenses based on their own made up process and timeline, but they are coming out non the less.

Congrats to all the license winners!

8And also congrats to all the new lawsuit plaintiffs who will be filing lawsuits against OCM for dripping out license’s arbitrarily.

Hot off the press. Brand new licenses coming out from OCM. Sure they’re going completely out of orde
May 15 · linkedin

The Office of Cannabis Management's newest FAQs, dropped yesterday, and bring crucial updates that could significantly shape the strategic landscape for cannabis businesses in New York. Here’s a breakdown of how some of these new regulations and how they may impact the market and licensees:

  1. Temporary Delivery Option (TDO) Limitations:   - Only TDO locations submitted prior to December 31, 2023, are eligible. All TDOs are temporary, expiring 12 months post provisional licensure unless extended.

  2. Ownership Flexibility in Licensing:   - Individuals can hold majority ownership in one retail dispensary while being a minority owner in another, without being a True Party of Interest (TPI) in both.   - *This flexibility encourages broader investment and participation in the industry by allowing entrepreneurs to diversify their business interests without violating ownership regulations. It also opens avenues for strategic partnerships and funding opportunities, though it demands careful management of ownership structures to stay within regulatory bounds.

  3. Procedure to Challenge Location Denials:   - Denied applicants from the November "priority" round can challenge the decision based on "public convenience and advantage" by compiling specific information and presenting it to the Board.   - *This process provides a fair recourse for applicants, potentially increasing competition in densely populated areas or markets perceived as saturated. It also offers a second chance for strategic site selection, although it requires understanding of regulatory compliance and the ability to present a compelling case to the Board.

  4. Cannabinoid Hemp Product Manufacturing and Sales:   - CBD Manufacturers in New York can produce THC cannabinoid-hemp products that EXCEED NY-state THC limits for products to be sold outside of New York.   - *Enables New York producers to tap into out-of-state markets where regulations are less restrictive, potentially boosting sales and expanding business footprints beyond state lines.

  • ** This makes very little sense to be honest. Effectively this means New York-based companies can produce products which are only legal to sell outside of New York, but ILLEGAL to sell in New York.

As usual with cannabis regulations. Gotta stay on your toes!!!

For a deeper dive into how these changes might specifically affect your business and strategic advice tailored to your situation, let’s connect!

David B. Feder, Esq
Add to my network

Location

New York, New York, United States